fexofenadine has been researched along with Allergic Rhinitis in 8 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An assessment of the severity of allergic rhinitis symptoms was performed for all patients (n = 260) pre- and 7 days into fexofenadine." | 3.79 | The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among Jordanians. ( Al-Azzam, SI; Alzoubi, KH; Khabour, OF; Mayyas, F, 2013) |
| "Allergic rhinitis is a condition with high global prevalence most effectively treated with antihistamines and antileukotrienes." | 3.01 | Bioavailability assessment of fexofenadine and montelukast in a fixed-dose combination tablet ( Everardo, PG; Gabriela, SC; Magdalena, GS; Maria Elena, GP; Vanessa, CM, 2021) |
| " However, the effect of long-term use of montelukast, a cystenil leukotriene receptor antagonist, on skin prick test hasn't been full elucidated." | 2.78 | The effect of montelukast on wheal reactions in skin prick tests: a double-blind-placebo-controlled randomized trial. ( Aydogan, M; Aydogmus, CY; Bulan, K; Siraneci, R, 2013) |
| "Nasal obstruction is one of the most bothersome symptoms of allergic rhinitis (AR) affecting sleep-related quality of life in AR patients." | 1.56 | Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis. ( Aoyagi, H; Hirasawa, N; Kajiwara, D; Miyoshi, K; Tanaka, K; Tsunekuni, K, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bagherinia, E | 1 |
| Falahi, S | 1 |
| Mortazavi, SH | 1 |
| Salari, F | 1 |
| Rezaiemanesh, A | 1 |
| Karaji, AG | 1 |
| Aoyagi, H | 1 |
| Kajiwara, D | 1 |
| Tsunekuni, K | 1 |
| Tanaka, K | 1 |
| Miyoshi, K | 1 |
| Hirasawa, N | 1 |
| Everardo, PG | 1 |
| Magdalena, GS | 1 |
| Maria Elena, GP | 1 |
| Vanessa, CM | 1 |
| Gabriela, SC | 1 |
| Liu, Y | 1 |
| Ye, XJ | 1 |
| Zhao, CL | 1 |
| Ji, Q | 1 |
| Derakhshan, A | 1 |
| Khodadoost, M | 1 |
| Ghanei, M | 1 |
| Gachkar, L | 1 |
| Hajimahdipour, H | 1 |
| Taghipour, A | 1 |
| Yousefi, J | 1 |
| Khoshkhui, M | 1 |
| Azad, FJ | 1 |
| Bulan, K | 1 |
| Aydogan, M | 1 |
| Siraneci, R | 1 |
| Aydogmus, CY | 1 |
| Alzoubi, KH | 1 |
| Khabour, OF | 1 |
| Al-Azzam, SI | 1 |
| Mayyas, F | 1 |
| Gunawardena, MD | 1 |
| Weerasinghe, A | 1 |
| Herath, J | 1 |
| Amarasena, N | 1 |
4 trials available for fexofenadine and Allergic Rhinitis
| Article | Year |
|---|---|
Bioavailability assessment of fexofenadine and montelukast in a fixed-dose combination tablet
Topics: Acetates; Area Under Curve; Biological Availability; Cross-Over Studies; Cyclopropanes; Humans; Quin | 2021 |
[The effect of combined therapy on seasonal allergic rhinitis].
Topics: Administration, Intranasal; Budesonide; Double-Blind Method; Glucocorticoids; Humans; Leukotriene An | 2016 |
Effects of a Novel Barley-Based Formulation on Allergic Rhinitis: A Randomized Controlled Trial.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Biomarkers; Child; Female; Histamine H1 Antagonists, | 2019 |
The effect of montelukast on wheal reactions in skin prick tests: a double-blind-placebo-controlled randomized trial.
Topics: Acetates; Allergens; Animals; Asthma; Chi-Square Distribution; Child; Cyclopropanes; Dose-Response R | 2013 |
4 other studies available for fexofenadine and Allergic Rhinitis
| Article | Year |
|---|---|
Co-treatment with Fexofenadine and Budesonide Increases FoxP3 Gene Expression in Patients with Allergic Rhinitis.
Topics: Budesonide; Forkhead Transcription Factors; Gene Expression; Humans; Immunoglobulin E; Nuclear Recep | 2023 |
Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis.
Topics: Acetates; Animals; Anti-Allergic Agents; Cell Line; Cyclopropanes; Disease Models, Animal; Drug Syne | 2020 |
The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among Jordanians.
Topics: Adult; Anti-Allergic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Tra | 2013 |
Myocardial infarction associated with eosinophilia and plasma extravasation at multiple sites. A variant of Kounis syndrome.
Topics: Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Eosinophilia; Humans; Hypersensitivity, Immed | 2015 |